Compstatins: the dawn of clinical C3-targeted complement inhibition
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Compstatins: the dawn of clinical C3-targeted complement inhibition
Authors
Keywords
complement system, C3 inhibitor, compstatin, pegcetacoplan, paroxysmal nocturnal hemoglobinuria (PNH)
Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-25
DOI
10.1016/j.tips.2022.01.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
- (2021) Peter Garred et al. PHARMACOLOGICAL REVIEWS
- Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
- (2021) Peter Hillmen et al. NEW ENGLAND JOURNAL OF MEDICINE
- From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors
- (2021) Dimitrios C. Mastellos et al. CLINICAL IMMUNOLOGY
- C3-targeted therapy in periodontal disease: moving closer to the clinic
- (2021) George Hajishengallis et al. TRENDS IN IMMUNOLOGY
- C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates
- (2021) Robin Schmitz et al. Nature Communications
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
- (2021) Da Shi et al. ADVANCED DRUG DELIVERY REVIEWS
- Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates
- (2020) Sarah Hughes et al. CLINICAL IMMUNOLOGY
- Assessment of the Role of C3(H2O) in the Alternative Pathway
- (2020) Karin Fromell et al. Frontiers in Immunology
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab
- (2020) Carlos Castro et al. AMERICAN JOURNAL OF HEMATOLOGY
- Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
- (2020) Panagiotis Skendros et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions
- (2020) Benjamin J. Kim et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical promise of next-generation complement therapeutics
- (2019) Dimitrios C. Mastellos et al. NATURE REVIEWS DRUG DISCOVERY
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration.
- (2019) David S. Liao et al. OPHTHALMOLOGY
- ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
- (2019) Dimitrios C. Mastellos et al. NATURE IMMUNOLOGY
- Therapeutic targeting of the complement system
- (2019) Daniel Ricklin et al. NATURE REVIEWS DRUG DISCOVERY
- Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum
- (2018) Peter J. Lachmann et al. FASEB JOURNAL
- New Analogs of the Complement C3 Inhibitor Compstatin with Increased Solubility and Improved Pharmacokinetic Profile
- (2018) Nadja Berger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement
- (2018) Deniz Ugurlar et al. SCIENCE
- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2018) Frank G. Holz et al. JAMA Ophthalmology
- Developments in anti-complement therapy; from disease to clinical trial
- (2018) Claire L. Harris et al. MOLECULAR IMMUNOLOGY
- A C3(H20) recycling pathway is a component of the intracellular complement system
- (2017) Michelle Elvington et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- (2017) James F Howard et al. LANCET NEUROLOGY
- The renaissance of complement therapeutics
- (2017) Daniel Ricklin et al. Nature Reviews Nephrology
- Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
- (2017) Simon A. Mortensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement component C3 - The “Swiss Army Knife” of innate immunity and host defense
- (2016) Daniel Ricklin et al. IMMUNOLOGICAL REVIEWS
- Complement in disease: a defence system turning offensive
- (2016) Daniel Ricklin et al. Nature Reviews Nephrology
- Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden and lower antigenic levels in familial AMD
- (2016) Erin K. Wagner et al. Scientific Reports
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
- (2015) Dimitrios C. Mastellos et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
- (2015) Lars G Fritsche et al. NATURE GENETICS
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
- (2014) Antonio M. Risitano et al. BLOOD
- Conjugation to Albumin-Binding Molecule Tags as a Strategy to Improve Both Efficacy and Pharmacokinetic Properties of the Complement Inhibitor Compstatin
- (2014) Yijun Huang et al. ChemMedChem
- Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
- (2014) C. A. Diebolder et al. SCIENCE
- Structural and Functional Overview of the Lectin Complement Pathway: Its Molecular Basis and Physiological Implication
- (2013) Misao Matsushita et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
- (2012) Hongchang Qu et al. IMMUNOBIOLOGY
- Synthesis and Activity of Thioether-Containing Analogues of the Complement Inhibitor Compstatin
- (2011) Patrick J. Knerr et al. ACS Chemical Biology
- Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal Neovascularization
- (2011) Valeriy V. Lyzogubov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency
- (2010) Hongchang Qu et al. MOLECULAR IMMUNOLOGY
- Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
- (2009) A. M. Risitano et al. BLOOD
- Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatin
- (2009) Paola Magotti et al. JOURNAL OF MOLECULAR RECOGNITION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now